Wolfe Research Reaffirms Peer Perform Rating for Shockwave Medical (NASDAQ:SWAV)

Shockwave Medical (NASDAQ:SWAV – Get Free Report)‘s stock had its “peer perform” rating reissued by equities researchers at Wolfe Research in a research report issued on Friday, MarketBeat Ratings reports. SWAV has been the subject of several other research reports. Needham & Company LLC increased their price objective on Shockwave Medical from $260.00 to $286.00 […]

Leave a Reply

Your email address will not be published.

Previous post PulteGroup (NYSE:PHM) Price Target Raised to $136.00
Next post Shockwave Medical (NASDAQ:SWAV) Given Hold Rating at Needham & Company LLC